Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Jan 2021 09:14

RNS Number : 5301L
Hikma Pharmaceuticals Plc
13 January 2021
 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge Darhold Limited over 4,400,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Citibank N.A. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 4,400,000

d)

Aggregated information

Aggregated volume: 4,400,000

Price: £0.00p

e)

Date of the transaction

13 January 2021

f)

Place of the transaction

Amman

 

 

Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge Darhold Limited over 4,400,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Citibank N.A. Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 4,400,000

d)

Aggregated information

Aggregated volume: 4,400,000

Price: £0.00p

e)

Date of the transaction

13 January 2021

f)

Place of the transaction

Amman

 

 

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge Darhold Limited over 4,400,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Citibank N.A. Darhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 4,400,000

d)

Aggregated information

Aggregated volume: 4,400,000

Price: £0.00p

e)

Date of the transaction

13 January 2021

f)

Place of the transaction

Amman

 

Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDBXBBDGBX
Date   Source Headline
3rd Jan 20237:00 amRNSHikma launches sodium oxybate in the US
1st Dec 20229:24 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSHikma Injectables Portugal site visit
22nd Nov 202211:38 amRNSHolding(s) in Company
17th Nov 20229:50 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSTrading Statement
13th Oct 20223:00 pmRNSDirectorate Change
5th Oct 202212:16 pmRNSHolding(s) in Company
4th Oct 202210:05 amRNSHolding(s) in Company
3rd Oct 20223:52 pmRNSBlock listing Interim Review
3rd Oct 20223:11 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSDirector changes and update on AGM 2022 resolution
14th Sep 20229:19 amRNSChange of Hikma interim dividend payment date
1st Sep 20222:25 pmRNSTotal Voting Rights
30th Aug 202212:22 pmRNSHikma launches RYALTRIS
23rd Aug 20223:12 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
1st Aug 20224:48 pmRNSTotal Voting Rights
18th Jul 20229:26 amRNSNotice of Results
1st Jul 202210:52 amRNSTotal Voting Rights
15th Jun 20223:00 pmRNSCompany Secretary Change
15th Jun 20221:46 pmRNSDirector/PDMR Shareholding
10th Jun 20226:08 pmRNSTransaction in Own Shares
9th Jun 20225:14 pmRNSTransaction in Own Shares
8th Jun 20225:15 pmRNSTransaction in Own Shares
7th Jun 20225:13 pmRNSTransaction in Own Shares
6th Jun 20225:14 pmRNSTransaction in Own Shares
1st Jun 20226:08 pmRNSTransaction in Own Shares
31st May 20225:52 pmRNSTransaction in Own Shares
31st May 202210:00 amRNSDirector/PDMR Shareholding
30th May 20225:23 pmRNSTransaction in Own Shares
27th May 20225:20 pmRNSTransaction in Own Shares
26th May 20225:20 pmRNSTransaction in Own Shares
25th May 20226:03 pmRNSTransaction in Own Shares
24th May 20225:53 pmRNSTransaction in Own Shares
24th May 20227:00 amRNSSiggi Olafsson to step down as Chief Executive
23rd May 20225:51 pmRNSTransaction in Own Shares
20th May 20225:37 pmRNSTransaction in Own Shares
20th May 202212:58 pmRNSResults of EGM
19th May 20226:15 pmRNSTransaction in Own Shares
18th May 20225:22 pmRNSTransaction in Own Shares
17th May 20225:49 pmRNSTransaction in Own Shares
16th May 20226:05 pmRNSTransaction in Own Shares
13th May 20225:41 pmRNSTransaction in Own Shares
12th May 20225:35 pmRNSTransaction in Own Shares
11th May 20225:19 pmRNSTransaction in Own Shares
11th May 20227:00 amRNSShare Buyback Programme
10th May 20225:18 pmRNSTransaction in Own Shares
9th May 20225:59 pmRNSTransaction in Own Shares
6th May 20225:54 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.